Newtyn Management, LLC Sio Gene Therapies Inc. Transaction History

Newtyn Management, LLC

  • $567 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.28 - $0.44 $420,000 - $660,000
1,500,000 Added 100.0%
3,000,000 $1.32 Million
Q3 2022

Nov 14, 2022
BUY
$0.28 - $0.41 $23,559 - $34,497
84,141 Added 5.94%
1,500,000 $420,000
Q2 2022

Aug 15, 2022
BUY
$0.25 - $0.73 $353,964 - $1.03 Million
1,415,859 New
1,415,859 $510,000

Others Institutions Holding SIOX

# of Institutions
2
Shares Held
147K
Call Options Held
0
Put Options Held
0
View Full List

About Sio Gene Therapies Inc.

SIOX Quotes by TradingView
  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Newtyn Management, LLC Portfolio

Follow Newtyn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email